NCW visits TCS Nashik: What the fact-finding committee will examine and why its report matters beyond this case
Read More Healthcare Industry News What Alamar Biosciences’ (NASDAQ: ALMR) IPO pop says about the next phase of proteomics investing Alamar Biosciences surged after its upsized IPO. Read what the debut means for proteomics, public markets, and life science tools investors. byPallavi MadhirajuApril 18, 2026